Godwin W Nchinda
Overview
Explore the profile of Godwin W Nchinda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torimiro J, Duri K, Goumkwa N, Atah S, Ndzie Ondigui J, Lobe C, et al.
Front Public Health
. 2024 Apr;
12:1283350.
PMID: 38645447
The WHO African Region had 81 million people with chronic hepatitis B in 2019, which remains a silent killer. Hepatitis B virus (HBV), hepatitis delta virus (HDV), and HIV can...
2.
Nchinda G, Al-Atoom N, Coats M, Cameron J, Waffo A
Viruses
. 2021 Apr;
13(4).
PMID: 33801772
Phage display technology involves the surface genetic engineering of phages to expose desirable proteins or peptides whose gene sequences are packaged within phage genomes, thereby rendering direct linkage between genotype...
3.
Sake C, Ngu L, Ambada G, Chedjou J, Nji N, Tchadji J, et al.
Biomed Hub
. 2020 Jan;
2(1):1-13.
PMID: 31988903
Background: In sub-Saharan Africa, intense perennial species transmission coincides with areas of high prevalence of the human immunodeficiency virus type 1 (HIV) infection. This implies that antiretroviral naïve HIV-infected people...
4.
Eleje G, Ogbunugafor H, Emegoakor C, Okoye E, Ezejiofor O, Chukwurah S, et al.
Clin Exp Gastroenterol
. 2019 Jan;
12:21-30.
PMID: 30679917
Background: To our knowledge, there is no prior randomized study on the utility of Syferol-IHP (blend of virgin coconut oil and oil) when coadministered with a triple therapy schedule. Aim:...
5.
Njambe Priso G, Lissom A, Ngu L, Nji N, Tchadji J, Tchouangueu T, et al.
BMC Infect Dis
. 2018 Apr;
18(1):160.
PMID: 29618330
Background: In West and Central Africa areas of endemic Loa loa infections overlap with regions of high prevalence of human immunodeficiency virus type 1 (HIV-1) infections. Because individuals in this...
6.
Judson S, LeBreton M, Fuller T, Hoffman R, Njabo K, Brewer T, et al.
Ecohealth
. 2017 Dec;
15(1):52-62.
PMID: 29230614
Recent outbreaks of Ebola virus disease and Zika virus disease highlight the need for disseminating accurate predictions of emerging zoonotic viruses to national governments for disease surveillance and response. Although...
7.
Ngu L, Nji N, Ambada G, Ngoh A, Njambe Priso G, Tchadji J, et al.
Immun Inflamm Dis
. 2017 Dec;
6(1):163-175.
PMID: 29205929
Introduction: Recombinant Newcastle Disease virus (rNDV) vectored vaccines are safe mucosal applicable vaccines with intrinsic immune-modulatory properties for the induction of efficient immunity. Like all viral vectored vaccines repeated inoculation...
8.
Ngu L, Nji N, Ambada G, Sagnia B, Sake C, Tchadji J, et al.
Immun Inflamm Dis
. 2017 May;
7(2):55-67.
PMID: 28474788
Introduction: Targeting antigens to dendritic cells (DCs) in vivo via a DC-restricted endocytic receptor, DEC205, has been validated to enhance immunity in several vaccine platforms. Particularly atttractive is selected delivery...
9.
Ambada G, Ntsama C, Nji N, Ngu L, Sake C, Lissom A, et al.
Immunology
. 2017 Apr;
151(4):405-416.
PMID: 28375551
Regulatory T (Treg) cells play a key role in dampening excessive immune activation. However, antiretroviral therapy (ART) -naive HIV-1 infection maintains the immune system in a sustained state of activation...